WTC
RNAM

WhitTier Trust Company’s Avidity Biosciences RNAM Stock Holding History

WhitTier Trust Company’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-78
Closed -$3.67K – 1307
2025
Q3 		$3.67K Buy
78
+30
+63% +$1.21K ﹤0.01% 1111
2025
Q2 		$1.36K Hold
48
– – ﹤0.01% 1341
2025
Q1 		$1.42K Buy
48
+21
+78% +$654 ﹤0.01% 1314
2024
Q4 		$784 Buy
27
+2
+8% +$84 ﹤0.01% 1288
2024
Q3 		$1.15K Buy
+25
New +$1.08K ﹤0.01% 1265

Other funds holding RNAM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WhitTier Trust Company's RNAM Position: Q4 2025 in Review

WhitTier Trust Company sold out of Avidity Biosciences (RNAM) in Q4 2025, closing a stake of 78 shares — an estimated $3.67K sold.

WhitTier Trust Company first reported a position in RNAM in Q3 2024 and held it in 5 quarters. The position peaked at $3.67K in Q3 2025. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • WhitTier Trust Company reported no remaining Avidity Biosciences position as of Q4 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 78 Avidity Biosciences shares in Q4 2025, an estimated $3.67K.
  • WhitTier Trust Company first reported a position in Avidity Biosciences in Q3 2024 and held it in 5 quarters.
  • WhitTier Trust Company's Avidity Biosciences position peaked at $3.67K in Q3 2025.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on WhitTier Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.